Atypical Teratoid Rhabdoid Tumor
📧 Sign up to get email alerts when something new happens for Atypical Teratoid Rhabdoid Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-08-27Clinical Trial Update: Ribociclib and Everolimus in Treating Children With Recurrent or Refractory Malignant Brain Tumors [Phase 1]
Phase 1 trial evaluating ribociclib with everolimus in pediatric patients with recurrent or refractory malignant brain tumors; completed wit…
-
CLINICAL_TRIALS research · 2018-07-16Clinical Trial Update: Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors
This clinical trial update describes the collection and storage of blood and brain tumor tissue samples from children with brain tumors for …
-
CLINICAL_TRIALS trial_result · 2017-08-07Clinical Trial Update: p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors [Phase 1]
This Phase 1 trial tests the safety of the p28 peptide in younger patients with recurrent or progressive central nervous system tumors and t…
-
CLINICAL_TRIALS research · 2016-07-14Clinical Trial Update: Studying Gene Expression in Samples From Patients With Rhabdoid Tumors
Clinical trial update describing a study that analyzes gene expression in rhabdoid tumor samples from patients, including central nervous sy…
-
CLINICAL_TRIALS trial_result · 2016-03-07Clinical Trial Update: AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors [Phase 1]
Phase 1 study of AZD2171 (cediranib) in children with recurrent, progressive, or refractory primary central nervous system tumors has comple…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-12-24Clinical Trial Update: Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RT [Phase 2]
Phase 2 trial evaluating chemotherapy combined with radiation therapy for newly diagnosed atypical teratoid/rhabdoid tumor of the central ne…
-
CLINICAL_TRIALS trial_result · 2014-11-05Clinical Trial Update: Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia [Phase 1]
Phase 1 study of RO4929097, a gamma-secretase inhibitor, in pediatric patients with relapsed or refractory solid tumors, CNS tumors, lymphom…
-
CLINICAL_TRIALS trial_result · 2014-06-17Clinical Trial Update: Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia [Phase 1]
Phase 1 study evaluating vorinostat with or without isotretinoin in pediatric patients with recurrent or refractory solid tumors, lymphoma, …
-
CLINICAL_TRIALS trial_result · 2014-02-27Clinical Trial Update: Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor [Phase 3]
Phase 3 clinical trial evaluating treatment for newly diagnosed medulloblastoma, supratentorial PNET, or atypical teratoid rhabdoid tumor; s…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors [Phase 1]
A Phase 1 clinical trial evaluated lenalidomide in young patients with recurrent, progressive, or refractory central nervous system tumors. …
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors [Phase 1]
Phase 1 evaluation of vorinostat in combination with temozolomide in children with relapsed or refractory primary brain tumors or spinal cor…
-
CLINICAL_TRIALS trial_result · 2009-10-15Clinical Trial Update: Oxaliplatin in Treating Children With Recurrent or Refractory Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor [Phase 2]
A Phase 2 clinical trial evaluating oxaliplatin in children with recurrent or refractory medulloblastoma, supratentorial primitive neuroecto…